valine Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Valine is an α-amino acid that is used in the biosynthesis of proteins. It is essential in humans, meaning the body cannot synthesize it and thus it must be obtained from the diet. There is a mixed scientivic evidence that as a dietary supplement valine improves training efficacy, delays central fatigue.   NCATS

Chemistry

  • SMILES: CC(C)[C@H](N)C(O)=O
  • InChIKey: KZSNJWFQEVHDMF-BYPYZUCNSA-N
  • Mol. Mass: 117.1463
  • ALogP: 0.05
  • ChEMBL Molecule:
    valine  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

2-amino-3-methylbutyric acid | (2s)-2-amino-3-methylbutanoic acid | l-alpha-amino-beta-methylbutyric acid | l-(+)-alpha-aminoisovaleric acid | l-valine | (s)-valine | val | valine

Organizations (6)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (1)


 

Burns (approved 1971)

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Fatigue ()

Liver Cirrhosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue